We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NAMM:NASDAQNamib Minerals Analysis

Data as of 2026-05-19 - not real-time

$1.40

Latest Price

8/10Risk

Risk Level: High

Executive Summary

The stock is trading just above a recent support level and technical momentum remains bearish, with the moving‑average hierarchy indicating a downtrend and a MACD spread that is still negative. RSI is well into oversold territory, suggesting a possible short‑term bounce but not enough to overturn the prevailing bearish bias. Beta is markedly high and recent volatility has been extreme, amplifying price swings and risk. Valuation multiples are exceptionally low, with a price‑to‑earnings ratio that is among the lowest in the market and a price‑to‑book figure that is negative, reflecting a market price that sits above the discounted cash‑flow estimate. The company generates positive operating cash flow and modest free cash flow while carrying a relatively small debt load, yet its book value per share is negative, underscoring balance‑sheet concerns. Recent corporate communications highlight a full‑year results release and ongoing production at its African mines, providing a tangible operational backdrop. Market sentiment is currently in a state of extreme greed, which could be inflating speculative interest despite the underlying fundamentals. Overall, the combination of bearish technicals, high volatility, and a precarious valuation framework points to a cautious outlook.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • bearish technical indicators
  • price near support
  • low liquidity

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • moderate cash generation
  • modest debt profile
  • commodity price exposure

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • potential upside relative to fair value
  • low valuation multiples
  • long‑run gold demand

Key Metrics & Analysis

Financial Health

Revenue Growth5.10%
Profit Margin122.50%
P/E Ratio0.8
ROA14.57%
P/B Ratio-1.9
Op. Cash Flow$13.8M
Free Cash Flow$3.2M

Technical Analysis

TrendBearish
RSI26.5
Support$1.35
Resistance$2.27
MA 20$1.79
MA 50$2.11
MA 200$2.37
MACDBearish
VolumeDecreasing
Fear & Greed Index88.88

Valuation

Fair Value$0.90
Target Price$9.50
Upside/Downside581.00%
GradeOvervalued
TypeBlend

Risk Assessment

Beta2.88
Volatility62.53%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.